iShares U.S. Pharmaceuticals ETF (IHE) Short Interest Ratio & Short Volume

Short interest is the volume of iShares U.S. Pharmaceuticals ETF shares that have been sold short but have not yet been covered or closed out. As of May 31st, traders have sold 479,900 shares of IHE short. 5.55% of iShares U.S. Pharmaceuticals ETF's shares are currently sold short. Learn More on iShares U.S. Pharmaceuticals ETF's current short interest.

The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. IHE shares currently have a short interest ratio of 4.0. Learn More on iShares U.S. Pharmaceuticals ETF's short interest ratio.

Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 5.55% of iShares U.S. Pharmaceuticals ETF's floating shares are currently sold short.

iShares U.S. Pharmaceuticals ETF saw a increase in short interest during the month of May. As of May 31st, there was short interest totaling 479,900 shares, an increase of 23.1% from the previous total of 390,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

5.55% of iShares U.S. Pharmaceuticals ETF's shares are currently sold short. Here is how the short interest of companies compare to iShares U.S. Pharmaceuticals ETF: VanEck Pharmaceutical ETF (41.19%), Direxion Daily S&P Biotech Bull 3x Shares (11.63%), iShares U.S. Healthcare Providers ETF (2.33%), Invesco S&P 500 Equal Weight Health Care ETF (1.19%), VanEck Biotech ETF (0.37%), Invesco Pharmaceuticals ETF (0.34%), First Trust Health Care AlphaDEX Fund (0.03%), Invesco Biotechnology & Genome ETF (0.03%), SPDR S&P Health Care Equipment ETF (0.51%), SPDR S&P Pharmaceuticals ETF (49.86%),

As of the most recent reporting period, the following stocks had the largest short interest positions: SPDR S&P 500 ETF Trust ($64.96 billion), Invesco QQQ ($27.88 billion), iShares Russell 2000 ETF ($19.94 billion), iShares 20+ Year Treasury Bond ETF ($9.69 billion), MicroStrategy Incorporated ($8.58 billion), SPDR S&P Biotech ETF ($5.72 billion), Invesco S&P 500 Equal Weight ETF ($5.45 billion), iShares iBoxx $ Investment Grade Corporate Bond ETF ($4.70 billion), Charter Communications, Inc. ($4.54 billion), and Industrial Select Sector SPDR Fund ($4.49 billion). View all of the most shorted stocks.

Short selling IHE is an investing strategy that aims to generate trading profit from iShares U.S. Pharmaceuticals ETF as its price is falling. IHE shares are trading up $0.71 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

A short squeeze for iShares U.S. Pharmaceuticals ETF occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of IHE, which in turn drives the price of the stock up even further.

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including IHE, twice per month. The most recent reporting period available is May, 31 2025.